This inventor holds 1 USPTO granted patent. Top assignee: Kite Pharma, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Chi Ying - Innovator in Binding Molecules
Introduction
Chi Ying is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of molecular biology, particularly with his innovative work on binding molecules. His expertise and dedication to research have led to the development of a patent that showcases his ingenuity.
Latest Patents
Chi Ying holds a patent for "GPC3 Binding Molecules." This invention is pivotal in advancing therapeutic approaches, particularly in targeting specific cancer cells. The patent reflects his commitment to improving medical treatments and enhancing patient outcomes.
Career Highlights
Chi Ying is currently employed at Kite Pharma, Inc., a leading biotechnology company focused on developing innovative cancer therapies. His role at Kite Pharma allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Chi Ying works alongside Matthew Drever, a fellow innovator at Kite Pharma. Their collaboration exemplifies the synergy of ideas and expertise that drives innovation in the biotechnology sector.
Conclusion
Chi Ying's contributions to the field of binding molecules and his work at Kite Pharma highlight his role as a key innovator in biotechnology. His patent and collaborations reflect a commitment to advancing medical science and improving patient care.